Avanos Medical (AVNS) Non Operating Interest Expenses (2013 - 2026)

Avanos Medical has disclosed Non Operating Interest Expenses across 14 years of filings, most recently posting $1.5 million for Q1 2026.

• In Q1 2026, Non Operating Interest Expenses fell 28.57% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $7.2 million (down 35.71% YoY), while the FY2025 annual figure was $7.8 million, down 36.07% from the prior year.
• Non Operating Interest Expenses came in at $1.5 million for Q1 2026 at Avanos Medical, down from $1.9 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $4.7 million in Q3 2023 to a low of $1.3 million in Q1 2022.
• Average Non Operating Interest Expenses over 5 years is $2.7 million, with a median of $3.0 million recorded in 2022.
• Year-over-year, Non Operating Interest Expenses jumped 328.57% in 2022 and slumped 43.75% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $3.0 million in 2022, then gained by 10.0% to $3.3 million in 2023, then slipped by 15.15% to $2.8 million in 2024, then slumped by 32.14% to $1.9 million in 2025, then declined by 21.05% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $1.5 million in Q1 2026, $1.9 million in Q4 2025, and $1.8 million in Q3 2025.